Investors

Following the sale of Warnex’s Bioanalytical Services division to Biotrial Research S.A.S. on December 10, 2012, the Corporation ceases to carry on any material active business operations, but will continue to maintain its corporate head office until further notice.

Financial Summary

	2007	2008	2009	2010	2011
Revenues (‘000 $)	25,499	25,787	23,647	22,251	21,258
Property, plant, equip. (‘000 $)	7,726	8,309	7,376	6,174	3,334
Net earnings (‘000 $)	(1,597)	2,373	(164)	(1,559)	487
Net earnings per share ($)	(0.03)	0.04	0.00	(0.02)	0.01